Cargando…

Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients

BACKGROUND: Venous thromboembolism (VTE) can be encountered by 60% of hospitalized patients. Anticoagulants have been recommended to reduce the risk of VTE in patients with risk factors. However, no specific dosing recommendations for obese patients are provided in the current practice guidelines. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Otaib, Nouf, Bootah, Zohour, Al Ammari, Maha A., Aldebasi, Tariq M., Alkatheri, Abdulmalik M., Al Harbi, Shmeylan A., AbuRuz, Salah M., AlBekairy, Abdulkareem M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541968/ https://www.ncbi.nlm.nih.gov/pubmed/28808492 http://dx.doi.org/10.4103/atm.ATM_31_17

Ejemplares similares

Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia
por: Al-Turaiki, Abdulrahman M., et al.
Publicado: (2016)

Medication discrepancies identified during medication reconciliation among medical patients at a tertiary care hospital
por: Al-Rashoud, Isra, et al.
Publicado: (2017)

Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patients
por: Al-Anazi, Alaa, et al.
Publicado: (2017)

Exploring quality of life among renal and liver transplant recipients
por: Alkatheri, Abdulmalik, et al.
Publicado: (2015)

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
por: Al-Debasi, Tariq, et al.
Publicado: (2017)

Does the patients’ educational level and previous counseling affect their medication knowledge?
por: Alkatheri, Abdulmalik M., et al.
Publicado: (2013)

The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation
por: Albekairy, Abdulkareem M., et al.
Publicado: (2018)

Pharmacy Students Perceptions of Their Distance Online Learning Experience During the COVID-19 Pandemic: A Cross-Sectional Survey Study
por: Shawaqfeh, Mohammad S, et al.
Publicado: (2020)

Validity and reliability of the Arabic version of the the EuroQOL (EQ-5D). A study from Saudi Arabia
por: Bekairy, Abdulkareem M., et al.
Publicado: (2018)

Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study
por: Almodaimegh, Hind, et al.
Publicado: (2017)

Hyponatremia management among patients admitted to tertiary hospital: A retrospective evaluation
por: Zurnuq, Sultan, et al.
Publicado: (2022)

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
por: Zachariah, Seeba, et al.
Publicado: (2020)

Strategic initiatives to maintain pharmaceutical care and clinical pharmacists sufficiency in Saudi Arabia
por: Albekairy, Abdulkareem M, et al.
Publicado: (2015)

Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study
por: Hakeam, Hakeam A., et al.
Publicado: (2020)

Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Synthesis, Antibacterial Evaluation and QSAR of α-Substituted-N(4)-Acetamides of Ciprofloxacin and Norfloxacin
por: Qandil, Amjad M., et al.
Publicado: (2014)

Comparison of the application of treatment Panel III and American College of Cardiology/American heart Association guidelines for blood cholesterol treatment in Saudi Arabia
por: Aburuz, Salahdein, et al.
Publicado: (2018)

742 Evaluation of Anti-Xa Levels and Venous Thromboembolism Prophylaxis with Enoxaparin in Burn Patients
por: Boyd, Allison, et al.
Publicado: (2023)

Pregnant women’s use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia
por: Al Essa, Mohammed, et al.
Publicado: (2019)

Cytochrome P450 3A4*1B as Pharmacogenomic Predictor of Tacrolimus Pharmacokinetics and Clinical Outcome in the Liver Transplant Recipients
por: Albekairy, Abdulkareem, et al.
Publicado: (2013)

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study
por: Matyjek, Anna, et al.
Publicado: (2021)

The Feasibility of Conducting Safe Objective Structured Clinical Exams (OSCEs) During the COVID-19 Era
por: Alshaya, Abdulrahman, et al.
Publicado: (2021)

The Pattern of Heparin Dosing as Venous Thromboembolism Prophylaxis in Adult Underweight Patients Admitted to Critical Care Units at a Tertiary Hospital
por: Al Harthy, Nouf, et al.
Publicado: (2022)

Application of the American College of Cardiology (ACC/AHA) 2017 Guideline for the Management of Hypertension in Adults and Comparison with the 2014 Eighth Joint National Committee Guideline
por: AlAhmad, Mohammad, et al.
Publicado: (2021)

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
por: Tahaineh, Linda, et al.
Publicado: (2018)

The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis
por: Al Harbi, Shmeylan A, et al.
Publicado: (2013)

Thromboembolic Diseases Among Intensive Care Unit Patients in Al-Qassim Region, Saudi Arabia
por: Harbi, Ayman, et al.
Publicado: (2022)

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022)

Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006)

The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
por: Korayem, Ghazwa B., et al.
Publicado: (2022)

Adherence and Treatment Satisfaction in Liver Transplant Recipients
por: Albekairy, Abdulkareem M., et al.
Publicado: (2016)

Investigating the association between severity of COVID-19 infection during pregnancy and neonatal outcomes
por: Dileep, Anita, et al.
Publicado: (2022)

Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management
por: AlAhmad, Mohammad M., et al.
Publicado: (2023)

Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study
por: Alsuhebany, Nada, et al.
Publicado: (2019)

Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study
por: Al Sulaiman, Khalid A., et al.
Publicado: (2021)

Revolutionizing healthcare: the role of artificial intelligence in clinical practice
por: Alowais, Shuroug A., et al.
Publicado: (2023)

Clinical characteristics and risk factors for mortality among COVID-19 hospitalized patients in UAE: Does ethnic origin have an impact
por: AbuRuz, Salah, et al.
Publicado: (2022)

Factor Xa Levels in Patients Receiving Prophylactic Enoxaparin Sodium in the Intensive Care Unit of an Academic Hospital
por: Baloo, Mayank M, et al.
Publicado: (2021)

Prevention of venous thromboembolism with enoxaparin in bariatirc surgery
por: Woo, Hee Doo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7gavf5jr0g9c2qdctr60h5dlfa